We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-4.48%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$387B
AUM Growth
-$17.5B
Cap. Flow
+$4.4B
Cap. Flow %
1.14%
Top 10 Hldgs %
31.87%
Holding
14,936
New
2,168
Increased
5,454
Reduced
5,272
Closed
1,852

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.17%
2 Technology 1.87%
3 Consumer Discretionary 1.66%
4 Communication Services 1.09%
5 Financials 1.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APLT
12501
DELISTED
Applied Therapeutics
APLT
$21K ﹤0.01%
22,740
+9,664
+74% +$11.6K
AQB icon
12502
PUT
AquaBounty Technologies
AQB
$6.74M
$21K ﹤0.01%
1,320
-5,205
-80% -$137K
ASMB icon
12503
Assembly Biosciences
ASMB
$709M
$21K ﹤0.01%
1,053
-277
-21% -$6.7K
BOXL icon
12504
Boxlight
BOXL
$4.07M
$21K ﹤0.01%
+24
New +$22.3K
CRIS icon
12505
Curis
CRIS
$3.64M
$21K ﹤0.01%
75
-81
-52% -$32.7K
HGBL icon
12506
Heritage Global
HGBL
$44.3M
$21K ﹤0.01%
+12,981
New +$21.6K
JOB icon
12507
GEE Group
JOB
$27.9M
$21K ﹤0.01%
+32,772
New +$20.3K
MREO
12508
CALL
Mereo BioPharma
MREO
$43.4M
$21K ﹤0.01%
23,900
-23,500
-50% -$28.8K
OWLT icon
12509
Owlet
OWLT
$146M
$21K ﹤0.01%
1,412
-15,088
-91% -$372K
CNSY
12510
Cerenome
CNSY
$23.5M
$21K ﹤0.01%
+123
New +$27.5K
RCON icon
12511
CALL
Recon Technology
RCON
$793K
$21K ﹤0.01%
10
-1
-9% -$2.41K
TDUP icon
12512
PUT
ThredUp
TDUP
$352M
$21K ﹤0.01%
+11,200
New +$28.1K
XFOR icon
12513
PUT
X4 Pharmaceuticals
XFOR
$419M
$21K ﹤0.01%
+413
New +$14.3K
AMAM
12514
DELISTED
Ambrx Biopharma Inc
AMAM
$21K ﹤0.01%
+19,220
New +$39.6K
LTRPA
12515
CALL
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$21K ﹤0.01%
19,700
-24,900
-56% -$26.2K
CGRN
12516
PUT
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$21K ﹤0.01%
+11,800
New +$27.3K
DTEA
12517
CALL
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$21K ﹤0.01%
29,400
+11,600
+65% +$15K
ACON icon
12518
Aclarion
ACON
$7.26M
0
AIMD icon
12519
Ainos
AIMD
$10.5M
$20K ﹤0.01%
+433
New +$22.7K
AKBA icon
12520
PUT
Akebia Therapeutics
AKBA
$260M
$20K ﹤0.01%
62,500
-36,000
-37% -$14.1K
CRDL
12521
Cardiol Therapeutics
CRDL
$241M
$20K ﹤0.01%
19,226
+5,632
+41% +$6.87K
EBON icon
12522
PUT
Ebang International Holdings
EBON
$13.9M
$20K ﹤0.01%
1,643
+710
+76% +$10.5K
MNTS icon
12523
PUT
Momentus
MNTS
$93.8M
$20K ﹤0.01%
1
-4
-80% -$92.6K
NNBR icon
12524
CALL
NN Inc
NNBR
$295M
$20K ﹤0.01%
11,600
-400
-3% -$970
NVVE
12525
PUT
DELISTED
Nuvve Holding Corp
NVVE
0

Similar funds

Jeff Yass's Q3 2022 Portfolio in Review

As of Q3 2022, Jeff Yass held 14,936 positions worth $387B, down 4.3% from $404B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q3 2022 filing shows 2,168 new, 5,454 increased, 5,272 reduced and 1,852 closed positions. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 714,572 shares worth $53.1M. The largest sale was Tesla, an estimated $799M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q3 2022 buy was Vanguard Short-Term Corporate Bond ETF: 714,572 shares worth $53.1M.
  • Jeff Yass added most to Amazon in Q3 2022, an estimated $1.21B increase.
  • Jeff Yass's biggest Q3 2022 reduction was Tesla, cutting an estimated $799M.
  • Jeff Yass fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $151M.
  • Jeff Yass's ten largest holdings make up 32% of its $387B portfolio in Q3 2022.
  • Jeff Yass opened 2,168 new positions and closed 1,852 in Q3 2022.
  • Jeff Yass's portfolio value fell 4.3% quarter-over-quarter to $387B.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.